These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 12270674)
1. Chemical stability of 2-arachidonylglycerol under biological conditions. Rouzer CA; Ghebreselasie K; Marnett LJ Chem Phys Lipids; 2002 Oct; 119(1-2):69-82. PubMed ID: 12270674 [TBL] [Abstract][Full Text] [Related]
2. Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. Basavarajappa BS; Saito M; Cooper TB; Hungund BL Biochim Biophys Acta; 2000 Dec; 1535(1):78-86. PubMed ID: 11113634 [TBL] [Abstract][Full Text] [Related]
3. Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories. Barnett-Norris J; Guarnieri F; Hurst DP; Reggio PH J Med Chem; 1998 Nov; 41(24):4861-72. PubMed ID: 9822555 [TBL] [Abstract][Full Text] [Related]
4. 2-Arachidonoylglycerol and the cannabinoid receptors. Sugiura T; Waku K Chem Phys Lipids; 2000 Nov; 108(1-2):89-106. PubMed ID: 11106784 [TBL] [Abstract][Full Text] [Related]
5. Selective oxygenation of the endocannabinoid 2-arachidonylglycerol by leukocyte-type 12-lipoxygenase. Moody JS; Kozak KR; Ji C; Marnett LJ Biochemistry; 2001 Jan; 40(4):861-6. PubMed ID: 11170406 [TBL] [Abstract][Full Text] [Related]
6. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Sugiura T; Kobayashi Y; Oka S; Waku K Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):173-92. PubMed ID: 12052034 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid. Laine K; Järvinen K; Mechoulam R; Breuer A; Järvinen T Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3216-22. PubMed ID: 12356827 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activities of novel structural analogues of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Suhara Y; Nakane S; Arai S; Takayama H; Waku K; Ishima Y; Sugiura T Bioorg Med Chem Lett; 2001 Aug; 11(15):1985-8. PubMed ID: 11454463 [TBL] [Abstract][Full Text] [Related]
9. Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. Bisogno T; Sepe N; Melck D; Maurelli S; De Petrocellis L; Di Marzo V Biochem J; 1997 Mar; 322 ( Pt 2)(Pt 2):671-7. PubMed ID: 9065792 [TBL] [Abstract][Full Text] [Related]
10. Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes. Savinainen JR; Järvinen T; Laine K; Laitinen JT Br J Pharmacol; 2001 Oct; 134(3):664-72. PubMed ID: 11588122 [TBL] [Abstract][Full Text] [Related]
11. Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. van der Stelt M; van Kuik JA; Bari M; van Zadelhoff G; Leeflang BR; Veldink GA; Finazzi-Agrò A; Vliegenthart JF; Maccarrone M J Med Chem; 2002 Aug; 45(17):3709-20. PubMed ID: 12166944 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in the synthesis of endocannabinoid related ligands. Razdan RK; Mahadevan A Chem Phys Lipids; 2002 Dec; 121(1-2):21-33. PubMed ID: 12505687 [TBL] [Abstract][Full Text] [Related]
13. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Sugiura T; Kishimoto S; Oka S; Gokoh M Prog Lipid Res; 2006 Sep; 45(5):405-46. PubMed ID: 16678907 [TBL] [Abstract][Full Text] [Related]
14. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. Gonsiorek W; Lunn C; Fan X; Narula S; Lundell D; Hipkin RW Mol Pharmacol; 2000 May; 57(5):1045-50. PubMed ID: 10779390 [TBL] [Abstract][Full Text] [Related]
15. A second endogenous cannabinoid that modulates long-term potentiation. Stella N; Schweitzer P; Piomelli D Nature; 1997 Aug; 388(6644):773-8. PubMed ID: 9285589 [TBL] [Abstract][Full Text] [Related]
16. Aqueous humor outflow effects of 2-arachidonylglycerol. Njie YF; He F; Qiao Z; Song ZH Exp Eye Res; 2008 Aug; 87(2):106-14. PubMed ID: 18597752 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice. Járai Z; Wagner JA; Goparaju SK; Wang L; Razdan RK; Sugiura T; Zimmer AM; Bonner TI; Zimmer A; Kunos G Hypertension; 2000 Feb; 35(2):679-84. PubMed ID: 10679517 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid. Fowler CJ; Jonsson KO; Andersson A; Juntunen J; Järvinen T; Vandevoorde S; Lambert DM; Jerman JC; Smart D Biochem Pharmacol; 2003 Sep; 66(5):757-67. PubMed ID: 12948856 [TBL] [Abstract][Full Text] [Related]
19. 2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts. Wagner JA; Abesser M; Harvey-White J; Ertl G J Cardiovasc Pharmacol; 2006 May; 47(5):650-5. PubMed ID: 16775503 [TBL] [Abstract][Full Text] [Related]
20. Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. Beltramo M; Piomelli D Neuroreport; 2000 Apr; 11(6):1231-5. PubMed ID: 10817598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]